ArticleLipids in health and disease2020

Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.

Eva O Melin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.